VR Adviser, LLC Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$778.5B
Holdings
26
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | TILINSTIL BIO INC | 6,865,076 | $122.7B | 15.76% | |
| 2 | ACRSACLARIS THERAPEUTICS INC | 4,563,962 | $82.2B | 10.55% | |
| 3 | TCE2CELLDEX THERAPEUTICS INC | 1,098,174 | $59.3B | 7.62% | |
| 4 | WHWKAADI BIOSCIENCE INC | 1,529,402 | $44.9B | 5.77% | |
| 5 | VTGNUSDVISTAGEN THERAPEUTICS INC | 16,047,286 | $44.0B | 5.65% | |
| 6 | ALTALTIMMUNE INC | 3,800,000 | $43.0B | 5.52% | |
| 7 | OLMAOLEMA PHARMACEUTICALS INC | 1,536,193 | $42.3B | 5.44% | |
| 8 | TVTXTRAVERE THERAPEUTICS INC | 1,732,410 | $42.0B | 5.40% | |
| 9 | RLMDRELMADA THERAPEUTICS INC | 1,387,720 | $36.4B | 4.67% | |
| 10 | GHRSGH RESEARCH PLC | 1,642,296 | $36.2B | 4.65% | |
| 11 | —KINNATE BIOPHARMA INC | 1,473,014 | $33.9B | 4.36% | |
| 12 | MRNS*MARINUS PHARMACEUTICALS INC | 2,641,809 | $30.1B | 3.86% | |
| 13 | GRPHGRAPHITE BIO INC | 1,612,617 | $26.4B | 3.39% | |
| 14 | CNTACENTESSA PHARMACEUTICALS PLC | 1,127,272 | $18.8B | 2.42% | |
| 15 | NUVLNUVALENT INC | 803,951 | $18.1B | 2.33% | |
| 16 | CRVSCORVUS PHARMACEUTICALS INC | 3,427,461 | $16.6B | 2.13% | |
| 17 | CGEMCULLINAN ONCOLOGY INC | 706,050 | $15.9B | 2.05% | |
| 18 | ATYRATYR PHARMA INC | 1,565,000 | $14.2B | 1.83% | |
| 19 | —ATHIRA PHARMA INC | 1,196,196 | $11.2B | 1.44% | |
| 20 | PHVSPHARVARIS NV | 552,882 | $9.8B | 1.26% | |
| 21 | COGTCOGENT BIOSCIENCES INC | 1,088,817 | $9.2B | 1.18% | |
| 22 | CVRXCVRX INC | 533,370 | $8.8B | 1.13% | |
| 23 | —AKOYA BIOSCIENCES INC | 400,000 | $5.6B | 0.72% | |
| 24 | CATBUSDASTRIA THERAPEUTICS INC | 538,999 | $4.8B | 0.61% | |
| 25 | 1T7TRICIDA INC | 390,707 | $1.8B | 0.23% | |
| 26 | VRDNVIRIDIAN THERAPEUTICS INC | 19,495 | $321.0M | 0.04% |